Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants. - Conley, Alexander C.; Key, Alexandra P.; Blackford, Jennifer U.; Russell, Jason K.; Albert, Kimberly M.; Gong, Xuewen; Bubser, Michael; Rook, Jerri M.; Conn, P. Jeffrey; Lindsley, Craig W.; Jones, Carrie K.; Newhouse, Paul A. (Alzheimer's Research & Therapy, 2025)